PF-07872411
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07872411, covering 2024-07-29 to 2024-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults [Phase 1]